The 2025 Microsoft Excel World Championship finals were held in Las Vegas on Dec. 2 and 3 Jordan Greene is Society and Culture writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her ...
A sprawling Houston estate once owned by former NBA star Nick Van Exel—and famously featured on MTV Cribs—is headed to the auction block, giving luxury buyers a rare shot at scooping up one of the ...
The Microsoft Excel World Championship 2025 wrapped up with yet another champion reigning supreme. This year’s champion beat out 23 Grand Final rivals at the Las Vegas HyperX Arena. The annual ...
But this year, the organisers have upped the ante. While the championship has experimented with wrestler-style intros before, in which competitors run down a tunnel to a smattering of muted applause ...
Microsoft is working to resolve a known issue that prevents some users from opening Excel email attachments in the new Outlook client. According to a service alert (EX1189359) seen by BleepingComputer ...
An illustration Anthropic commissioned to mark the release of Opus 4.5. (Anthropic) Hot on the heels of Google's Gemini 3 Pro release, Anthropic has announced an update for its flagship Opus model.
Nick Van Exel was there during Kobe Bryant's formative years in the NBA and figured some things just don't change. For instance, young Kobe always had that dog mentality, so much so that he had to be ...
Microsoft’s new Copilot function in Excel lets users generate, analyze and explain data directly from cell formulas, marking a major step toward full AI integration within spreadsheets. Microsoft’s ...
Anthropic is making its most aggressive push yet into the trillion-dollar financial services industry, unveiling a suite of tools that embed its Claude AI assistant directly into Microsoft Excel and ...
Excel’s newest Copilot integration finally delivers the data intelligence Microsoft promised years ago, transforming how users clean, organize and understand information within their spreadsheets. Way ...
EXEL recently reported STELLAR-303 trial results for zanzalintinib plus atezolizumab vs. regorafenib in metastatic colorectal cancer. The trial met its primary endpoint of overall survival, but the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback